Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2013 Financial Results
Date:11/5/2013

DUBLIN, Nov. 5, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2013 and updated 2013 financial guidance.

"We continued to deliver strong growth and profitability during the third quarter while further strengthening our cash position," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals plc. "With disciplined investments and successful execution of our corporate growth strategy, we believe we are well positioned to continue to generate significant growth and shareholder value."

Adjusted net income for the third quarter of 2013 was $109.4 million, or $1.78 per diluted share, compared to $78.6 million, or $1.29 per diluted share, for the third quarter of 2012.

GAAP net income for the third quarter of 2013 was $75.4 million, or $1.23 per diluted share. GAAP income from continuing operations for the third quarter of 2012 was $33.6 million, or $0.56 per diluted share, and GAAP net income for the third quarter of 2012 was $33.2 million, or $0.55 per diluted share. GAAP net income for the third quarter of 2012 included GAAP loss from discontinued operations of $0.4 million, or $0.01 per diluted share.

Reconciliations of applicable GAAP reported to non-GAAP adjusted information are included in this press release.

Third Quarter 2013 Revenues and Product SalesTotal revenues for the third quarter of 2013 were $232.2 million, compared to total revenues of $175.5 million for the third quarter of 2012. This increase was driven primarily by increased net sales of Xyrem and Erwinaze. Total revenues include net sales, royalties and contract revenues.

Tables showing net sales for the three and nine months ended September 30, 2013 compared to actual and pro forma net sales for the same periods in 2012 are included in this press release.<
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
2. Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
3. Jazz Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference on November 12
4. Immune Pharmaceuticals Appoints Liquidity Provider to Facilitate Trading on NASDAQ OMX Stockholm Exchange
5. Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11
6. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
8. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
9. Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
11. Cumberland Pharmaceuticals To Announce Third Quarter 2013 Financial Results On November 5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 Alexza Pharmaceuticals, Inc. (Nasdaq: ... quarter ended March 31, 2015.  The net loss and ... $0.4 million and $13.0 million, respectively, compared to $10.7 ... 2014, respectively.  At March 31, 2015, Alexza had consolidated ... $23.9 million. "We continue to focus on ...
(Date:5/6/2015)... , May 6, 2015 /CNW/ - Celebrities, bloggers and influencers across ... media to spread the important message that melanoma prevention begins ... Maria Sharapova , Hilary Duff , and parenting ... reached out to their networks on Monday to share this ... watch The David Cornfield Melanoma Fund ...
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research ... announced the addition of the "Cannulas Market ... Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) ... Global Forecast to 2020" report to their ... expected to grow at a CAGR of 5.6% ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3
... TAXUS(R) Element(TM) Stent now available in select markets ... (NYSE: BSX ) today announced the ... Coronary Stent System in select markets worldwide. ... chromium alloy engineered specifically for coronary stent applications ...
... Pa., May 18 MEDRAD Interventional(TM)/Possis(R) today announced ... the Paccocath(R) Technology closer to market as an ... the United States and Europe who suffer from ... selection of physician investigators for U.S. clinical trials ...
Cached Medicine Technology:Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 2Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 3Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 4Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 5Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 2Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 3Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 4Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data 5
(Date:5/6/2015)... As the exclusive hospital of the Tampa ... Pirate Ship at Raymond James Stadium for all the “Bucs ... to be drafted into the “Bucs Babies” program last year. ... time with children, particularly those born at the Florida Hospitals ... Buccaneers fans. I really enjoyed my time participating in the ...
(Date:5/6/2015)... May 06, 2015 Edvance360 LMS-SN ... announced it won the Software & Information Industry ... in the "Best Postsecondary Learning Management Solution" category. ... has been finalists for this award seven years running, ... stands out in the industry. , "The honor ...
(Date:5/6/2015)... May 06, 2015 As Hilo ... HIMSS EMR Adoption Model, the hospital looked for ... engagement and automate processes. The leadership team realized ... to electronic workflows, patient registration still required patients ... consents. With HIMSS Stage 7 attestation fast approaching, ...
(Date:5/6/2015)... Lewisberry, PA (PRWEB) May 06, 2015 A quality ... option for a functional yet practical way to raise chickens on ... coop by Chicken Coop Condo, it will have a chicken tractor ... It will last for many years, as it is able to ... help control which areas of the land are fertilized, and it ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair ... will now conduct their cooling services, including air conditioning ... commercial and residential units. Strata complex air conditioning services ... technical knowledge as well as a professionally trained staff. ... take away any old air conditioning unit to be ...
Breaking Medicine News(10 mins):Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2
... supports round-the-clock monitoring , , FRIDAY, Oct. 5 (HealthDay News) ... nighttime blood pressure readings are better indicators of health ... findings support recording the ambulatory blood pressure during the ... the Oct. 6 issue of The Lancet. ...
... between, Hospitals, Coding and Patient Financial Services Departments to Positively ... ... Oct. 5 CareTech Solutions, an information,technology (IT) and health ... today that Charlie Robinson,RHIT, CCS-P, iDoc(TM) Implementation Manager, will deliver ...
... a safe and effective alternative to standard ambulance transfer ... injury or illness, finds a study published on ... 21% of visits to hospital emergency departments and previous ... manage certain conditions in the community. But current research ...
... and chronic traumatic brain injury is not strong, concludes ... such, the researchers say they cannot firmly prove nor ... brain injury. , Although the evidence for chronic traumatic ... than that in professional boxing, the safety of amateur ...
... consumers stay put in their,current Medicare prescription drug ... in their monthly premiums for 2008, says new ... CMS data and its proprietary DataFrame(R),database, Avalere experts ... Part D marketplace. Under this method, the premiums ...
... announced the,promotion of Kirk Cianciolo, D.O., MBA, CPE to ... Dr. Cianciolo is a seasoned medical,professional, with more than ... physician executive. He has been with AvMed since 2006, ... In his new position, Dr. Cianciolo will continue ...
Cached Medicine News:Health News:Daytime, Nighttime Blood Pressure Both Important 2Health News:Daytime, Nighttime Blood Pressure Both Important 3Health News:CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit 2Health News:Paramedics can provide an effective alternative to standard ambulance service in the community 2Health News:No strong evidence linking amateur boxing with long-term brain injury 2Health News:Average Medicare Prescription Drug Premiums to Rise 21% 2Health News:AvMed Promotes Kirk Cianciolo to Senior Vice President and Chief Medical Officer 2
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
... of door controllers, RoamAlert Integrity Plus adds ... coverage area. These receivers pick up the ... in size and shape, this tag differs ... ECO and RoamAlert Integrity in one way: ...
... Awarix provides an enterprise visibility solution ... improve caregiver effectiveness, and increase patient ... RFID location systems and geospatial visual ... to create a real time patient ...
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
Medicine Products: